Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Post by righand99on Feb 08, 2016 7:54pm
63 Views
Post# 24537743

Cannabis Science Inc. targets autism treatment....

Cannabis Science Inc. targets autism treatment....Cannabis Science Inc. targets autism treatment

COLORADO SPRINGS, CO – Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced its next critical ailment target is autism and brings Mieko Hester-Perez on its Scientific Advisory Board to lead this charge.

Autismbrain

Mieko gained significant recognition for bringing her son’s success with medical cannabis to the public and birthing the significant “Joey’s Strain.” The Company has begun preliminary protocols to initiate formal studies with Mieko on autism in adults and children spotlighting successful treatments using cannabinoids.

Please visit https://www.miekosblog.com to watch and learn from Mieko’s incredible journey with her son Joey. Mieko used medical cannabis to treat her son “Joey” with autism symptoms, and has seen great progress since starting the treatment. As an autism advocate for the new cannabis patient base special needs families, Mieko has co-founded The Unconventional Foundation for Autism, https://UF4A.org, an informational website. She has even received Congressional Honors for her community service work with special needs children.

“When I decided to go public with my son’s success with medical cannabis for autism I was invited on FOX Morning News, The Doctors Show, The Dr. Juan Rivera Show, NBC syndicates, CBS, Good Morning America with Diane Sawyer, and ‘Inspiring Parents’ on ABC’s 20/20 special segments. I’ve been privileged to gracefully bridge two misunderstood communities with the help of High Times, Autism Spectrum Magazine, and numerous publications as a pioneer to these ground breaking cannabinoid treatments,” stated Ms. Hester-Perez.

As a board member for NORML’s Woman’s Alliance, Mieko Hester-Perez is a proven, knowledgeable, and key figure in the legal cannabis arena. Ms. Hester-Perez on a national platform remains a valuable source of information and support for parents with children requesting cannabinoid treatments until further laws are passed for special needs families who have exhausted all other treatment options. Since becoming a public figure standing on the front lines for special needs families she continues to provide effective navigation guidance to families on this safe, natural, and effective cannabis treatment.

“I am excited we are moving forward with Cannabis Science. In a recent event for Ron Dellums, the CBIS team met in California to discuss its progress on various initiatives. I was fortunate to be in that meeting with some of our key people, such as Ron Dellums, Dr. Allen Herman our CMO, Mel Foote, Mr. Dabney, along with a few others. I am very proud to be a part of this team; it gives me extra strength in multiple areas to move forward to reach my goals of providing continued autism treatments and education for children and their families worldwide, and I firmly believe the Cannabis Science Team is going to help me accomplish these goal immediately and provide some of the tools for me to move forward beyond my expectations. I plan to leverage Cannabis Science’s combined experience and fast track my ‘Joey’s Experience’ into a formal study that can positively impact families going through it. We are providing valuable education and real time access to information based on what I have been going through for many years,” concludes, Ms. Hester-Perez.


Bullboard Posts